NCT00698802View on ClinicalTrials.gov

Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL

Enrollment

397

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

EX1000

Treat-to-target titration scheme, s.c. injection

DRUG

biphasic human insulin

Treat-to-target titration scheme, s.c. injection

Trial Locations (3)

2193

Johannesburg

51900

Abu Dhabi

520002

Vijayawada

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY